Zhu YY - Search Results

1

Letter: the liver to abdominal area ratio--a novel imaging score for prognostication in cirrhosis.

Chen J, Patel SK, Lin S, Zhu YY. Chen J, et al. Among authors: zhu yy. Aliment Pharmacol Ther. 2016 Mar;43(5):659-60. doi: 10.1111/apt.13520. Aliment Pharmacol Ther. 2016. PMID: 26843350 No abstract available.

2

[Circadian clock and non-alcoholic fatty liver disease].

Lin YJ, Lin S, Wu YL, Zhu YY. Lin YJ, et al. Among authors: zhu yy. Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):284-288. doi: 10.3760/cma.j.cn501113-20200304-00084. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32306666 Review. Chinese.

3

[Damage-associated molecular patterns and liver failure].

Yan YY, Lin S, Zhu YY. Yan YY, et al. Among authors: zhu yy. Zhonghua Gan Zang Bing Za Zhi. 2016 Aug 20;24(8):636-640. doi: 10.3760/cma.j.issn.1007-3418.2016.08.017. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27788716 Review. Chinese.

4

[NACHT-LRR-PYD-containing proteins 3 inflammasome and nonalcoholic fatty liver disease].

Gao XJ, Lin S, Zhu YY. Gao XJ, et al. Among authors: zhu yy. Zhonghua Gan Zang Bing Za Zhi. 2016 Dec 20;24(12):956-960. doi: 10.3760/cma.j.issn.1007-3418.2016.12.019. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 28073424 Review. Chinese.

5

[Correlation between interleukin-6 single nucleotide polymorphism and the occurrence and prognosis of hepatitis B virus-associated acute-on-chronic liver failure].

Lin YH, Lin S, Zhou Q, Wang MF, Zhu YY. Lin YH, et al. Among authors: zhu yy. Zhonghua Gan Zang Bing Za Zhi. 2019 Apr 20;27(4):250-255. doi: 10.3760/cma.j.issn.1007-3418.2019.04.003. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31082334 Chinese.

6

[Expression of serum IgG4 in patients with non-IgG4-related hepatobiliary diseases].

Zhou Q, Lin S, Lin YH, Zhu YY. Zhou Q, et al. Among authors: zhu yy. Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):152-154. doi: 10.3760/cma.j.issn.1007-3418.2020.02.010. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32164067 Chinese.

7

[Efficacy of sequential therapy with telbivudine in treatment of HBeAg-positive chronic hepatitis B patients with partial response to pegylated interferon-α therapy].

Zhang Y, Zheng Q, Chen J, Jiang JJ, Zhu YY. Zhang Y, et al. Among authors: zhu yy. Zhonghua Gan Zang Bing Za Zhi. 2018 Feb 20;26(2):102-107. doi: 10.3760/cma.j.issn.1007-3418.2018.02.006. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 29804375 Chinese.

8

Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss.

Zheng Q, Zhu YY, Chen J, Liu YR, You J, Dong J, Zeng DW, Gao LY, Chen LH, Jiang JJ. Zheng Q, et al. Among authors: zhu yy. J Viral Hepat. 2014 Dec;21(12):909-16. doi: 10.1111/jvh.12261. Epub 2014 Jun 1. J Viral Hepat. 2014. PMID: 24888640

9

Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.

Zheng Q, Zhu YY, Chen J, Ye YB, Li JY, Liu YR, Hu ML, Zheng YC, Jiang JJ. Zheng Q, et al. Among authors: zhu yy. Clin Exp Immunol. 2015 Jun;180(3):499-508. doi: 10.1111/cei.12597. Epub 2015 Apr 12. Clin Exp Immunol. 2015. PMID: 25639451 Free PMC article.

10

Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.

Dou X, Zhou Q, Wen M, Xu J, Zhu Y, Zhang S, Xu X. Dou X, et al. Front Pharmacol. 2020 Jan 31;10:1700. doi: 10.3389/fphar.2019.01700. eCollection 2019. Front Pharmacol. 2020. Retraction in: Front Pharmacol. 2023 Jan 05;13:1129216. doi: 10.3389/fphar.2022.1129216 PMID: 32082174 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters